L'Istituto - About us

La Ricerca - Research

Attività Clinica - Clinic Activities

Come Sostenerci - How you can help

scientific articles|articoli scientifici

  

  
Sort by: Newest First | Oldest First
61 - 70 of 97 Results

  1. Categorie di popolazione a rischio di mesotelioma in Italia: il caso degli esposti ad asbesto nelle Ferrovie   View Pdf d

    Maltoni C. 1999.
    Eur J Oncol 4:395-398, 1999.

  2. Il cancro, il grande problema sanitario dell'Era Industriale: la necessità di ricerca e di prevenzione primaria   View Pdf d

    Maltoni C, Soffritti M, Minardi F, Belpoggi F, Palazzini A, Vrahulaki C. 1999.
    Eur J Oncol 4:345-359, 1999.

  3. Mesotelioma pleurico da esposizione ad amianto liberato da coperture edilizie   View Pdf d

    Maltoni C, Di Bisceglie M, Pinto C. 1999.
    Eur J Oncol 4:00-00, 1999.

  4. Mesotelioma in moglie di meccanico di auto insorto in seguito ad esposizione familiare ad asbesto   View Pdf d

    Maltoni C, Pinto C, Di Bisceglie M. 1999.
    Eur J Oncol 4:159-162, 1999.

  5. Mesotelioma pleurico in collaudatore e manutentore di camion anti-incendio esposto ad asbesto   View Pdf d

    Maltoni C, Di Bisceglie M, Pinto C. 1999.
    Eur J Oncol 4:155-157, 1999.

  6. Mesotelioma peritoneale in operaia addetta alla tessitura di manufatti a base di asbesto   View Pdf d

    Mussa B, Goss M, Moscato R, Di Bisceglie M, Pinto C, Maltoni C. 1999.
    Eur J Oncol 5:57-64, 1999.

  7. Mesotelioma pleurico da asbesto in lavoratore di uno stabilimento petrolchimico   View Pdf d

    Maltoni C, Di Bisceglie M, Pinto C. 1999.
    Eur J Oncol 4:65-69, 1999.

  8. Uncertainty in the risk assessment of environmental and occupational hazards

    Eds: Bailar JC, Bailer AJ, Belpoggi F, Brazier JV, Soffritti M, Maltoni C. 1999.
    Ann NY Acad Sci 895, 1999.

  9. The scientific and methodological bases of experimental studies for detecting and quantifying carcinogenic risks   View Pdf d

    Maltoni C, Soffritti M, Belpoggi F. 1999.
    Ann NY Acad Sci 895:10-26, 1999.

  10. Mega-experiments to identify and assess diffuse carcinogenic risks   View Pdf d

    Soffritti M, Belpoggi F, Minardi F, Bua L, Maltoni C. 1999.
    Ann NY Acad Sci 895:34-55, 1999.

Page: 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10   Prev  Next

November 15, 2008
EHP commentary argues the limits of 2-year bioassay exposure regimens: Ramazzini lifespan studies aspartame and toluene cited.
In a recent commentary entitled "The limits of 2-Year Bioassay Exposure Regimens for Identifying Chemical Carcinogens"Environ Health Perspect 116:11, 2008, authors James Huff, Devra Davis and Michael Jacobson argue that the sensitivity of chemical carcinogenesis bioassays would be enhanced by exposing rodents beginning in utero and continuing for 30 months (130 weeks) or until their natural deaths at up to about 3 years. Citing lifespan studies conducted by the European Ramazzini Foundation on aspartame and toluene the authors conclude that observing rodents until their natural deaths (i.e the Ramazzini lifespan model) increases the sensitivity of bioassays, avoids false-negative results, and strengthens the value and validity of results for regulatory agencies.
archive/archivio